James M. Ford

31.9k citations

332 papers · 17.7k indexed · 3 hit papers · h-index 76

Impact in

Oncology top 0.1%
- Cancer-related Molecular Pathways
- Pancreatic and Hepatic Oncology Research
- Drug Transport and Resistance Mechanisms
Cancer Research top 0.2%
- Cancer Genomics and Diagnostics

Papers in

Cancer Research 79
- Cancer Genomics and Diagnostics 68
Oncology 128
- Cancer-related Molecular Pathways 30
- Pancreatic and Hepatic Oncology Research 27
- PARP inhibition in cancer therapy 23

Co-authors: W N Hait Philip C. Hanawalt Shanthi Adimoolam George A. Fisher Allison W. Kurian P.C. Hanawalt Albert C. Koong Gilbert Chu
Journals: Journal of Clinical Oncology (54 papers)International Journal of Radiation Oncology*Biology*Physics (19 papers)Cancer Research (13 papers)Schizophrenia Bulletin (9 papers)DNA repair (8 papers)
Partner nations: United States United Kingdom Hong Kong

In The Last Decade

James M. Ford

323 papers receiving 17.2k citations

Hit Papers

align trajectories log scale

Single-cell analyses define a continuum of cell state and composition changes in the malignant transformation of polyps to colorectal cancer 2022 · 154 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2022 Nature Genetics
2015 Journal of Clinical Oncology
1990 Pharmacological Reviews

Peers

Countries citing papers authored by James M. Ford

Since Specialization

Citations

This map shows the geographic impact of James M. Ford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James M. Ford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James M. Ford more than expected).

Fields of papers citing papers by James M. Ford

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James M. Ford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James M. Ford. The network helps show where James M. Ford may publish in the future.

Co-authorship network

The 25 scholars most cited alongside James M. Ford, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with James M. Ford Line = papers co-authored together James M. Ford links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Functional characterization of SDHB variants clarifies hereditary pheochromocytoma and paraganglioma risk and genotype-phenotype relationships Journal of Clinical Investigation ·Sooyeon Lee, Walter Friedensburg, Julie R. Park, Rebecca C. Schugar, Omer Diker Halil, James M. Ford, Justin P. Annes	2025	0
2	An eMERGEing definition of patient engagement in genetic counseling Journal of Genetic Counseling ·B.J. Evans, Nie Shuai-ju, Claire Barton, Eziashi Ei, Luiz Felipe Domingos, М.А. Егорова, Stephan Andreas Sсhunk, 邦久秋山, W. Stefurak, WenCong Liu, Brianna M. Tucker, James M. Ford	2024	0
3	Clinical implications of conflicting variant interpretations in the cancer genetics clinic Genetics in Medicine ·Livia Oliveira O. Munhoz Soares, Julie O. Culver, Yuxi Liu, Yeong Suk Shim, Charité Ricker, Rachel Hodan, Antonella Ippolito, Kerry Kingham, Nicolette M. Chun, W. Stefurak, Kathryn Singh, Jason A. Zell, Uri Ladabaum, Kevin McDonnell, James M. Ford, Giovanni Parmigiani, Danielle Braun, Allison W. Kurian, Stephen B. Gruber, Gregory Idos	2023	3
4	A method for estimating and characterizing explicitly nonlinear dynamic functional network connectivity in resting-state fMRI data Journal of Neuroscience Methods ·Zhao Hui, Bogdan Tosza, Karima Putri Rahmadina, Ayşenil Belger, Juan Bustillo, Ashkan Faghiri, James M. Ford, Armin Iraji, Kelvin O. Lim, Daniel H. Mathalon, Robyn L. Miller, Bryon A. Mueller, Daniel S. OʼLeary, Steven G. Potkin, Adrian Preda, T.G. van Erp, Vince D. Calhoun	2023	11
5	Therapeutic Implications of Oncogenic Missense HER2 (ERBB2) Mutations in Gastric Adenocarcinoma JCO Precision Oncology ·Daniel A. King, Cornelius Qaqara, E Orinus, Meredith Mills, Elouise Mair, George A. Fisher, James M. Ford, Carlos J. Suarez	2023	2
6	Universal Screening of Gastrointestinal Malignancies for Mismatch Repair Deficiency at Stanford JNCI Cancer Spectrum ·HAFIDH MAKSUM, Navika Shukla, Yi Huang, Teri A. Longacre, Shyam S. Raghavan, Colin C. Pritchard, George A. Fisher, James M. Ford, Sigurdís Haraldsdóttir	2020	9
7	High-Resolution Bisulfite-Sequencing of Peripheral Blood DNA Methylation in Early-Onset and Familial Risk Breast Cancer Patients Clinical Cancer Research ·Justin Chen, Maria K. Haanpää, Joshua J. Gruber, Natalie Jäger, James M. Ford, M Snyder	2019	11
8	Comprehensive genomic characterization of breast tumors with BRCA1 and BRCA2 mutations BMC Medical Genomics ·Avantika Lal, Daniele Ramazzotti, Ziming Weng, Keli Liu, James M. Ford, Arend Sidow	2019	16
9	Higher Absolute Lymphocyte Counts Predict Lower Mortality from Early-Stage Triple-Negative Breast Cancer Clinical Cancer Research ·Anosheh Afghahi, Natasha Purington, Summer S. Han, Manisha Desai, Emma Pierson, Maya B. Mathur, Tina Seto, Caroline A. Thompson, Joseph Rigdon, Melinda L. Telli, Sunil Badve, Christina Curtis, Robert B. West, Kathleen C. Horst, Scarlett Lin Gomez, James M. Ford, George W. Sledge, Allison W. Kurian	2018	67
10	Tumor BRCA1 Reversion Mutation Arising during Neoadjuvant Platinum-Based Chemotherapy in Triple-Negative Breast Cancer Is Associated with Therapy Resistance Clinical Cancer Research ·Anosheh Afghahi, Kirsten M. Timms, Shaveta Vinayak, Kristin C. Jensen, Allison W. Kurian, Robert W. Carlson, Hafifatul Aulya Rahmy, Elizabeth Schackmann, Anne‐Renee Hartman, James M. Ford, Melinda L. Telli	2017	55
11	A Retrospective Analysis of Precision Medicine Outcomes in Patients With Advanced Cancer Reveals Improved Progression-Free Survival Without Increased Health Care Costs Journal of Oncology Practice ·Derrick S. Haslem, Dawid Louw, 和夫勝又, Andrew J. Knighton, Tom Belnap, Allison Butler, Zaid Al-Ali, David Newman, Heather Gilbert, Bea Roberts, Karen Lin, Nikianaku Seisagita Ardya, S Homrowski, Pravin J. Mishra, Rajendu Srivastava, James M. Ford, Lincoln Nadauld	2016	74
12	Therapeutic Targeting of BRCA1 -Mutated Breast Cancers with Agents That Activate DNA Repair Cancer Research ·Elizabeth Alli, David E. Solow-Cordero, Stephanie C. Casey, James M. Ford	2014	21
13	Oncogenic BRAF Mutation with CDKN2A Inactivation Is Characteristic of a Subset of Pediatric Malignant Astrocytomas Cancer Research ·Joshua D. Schiffman, John Hodgson, Scott R. VandenBerg, Patrick Flaherty, Mei‐Yin C. Polley, Mamie Yu, Paul G. Fisher, David H. Rowitch, James M. Ford, Mitchel S. Berger, Hanlee P. Ji, David H. Gutmann, C. David James	2010	185
14	Synergistic Chemosensitivity of Triple-Negative Breast Cancer Cell Lines to Poly(ADP-Ribose) Polymerase Inhibition, Gemcitabine, and Cisplatin Cancer Research ·Kedar Hastak, Elizabeth Alli, James M. Ford	2010	127
15	Defective Repair of Oxidative DNA Damage in Triple-Negative Breast Cancer Confers Sensitivity to Inhibition of Poly(ADP-Ribose) Polymerase Cancer Research ·Elizabeth Alli, von Gudrun Laue M, June Julian, James M. Ford	2009	111
16	Working memory and DLPFC inefficiency in schizophrenia: The FBIRN study Schizophrenia Bulletin ·Steven G. Potkin, Jessica A. Turner, Greg Brown, Gregory McCarthy, Doug Greve, Gary H. Glover, Dara S. Manoach, Ayşenil Belger, Michèle T. Diaz, Cynthia G. Wible, James M. Ford, Daniel H. Mathalon, Randy L. Gollub, John Lauriello, Daniel S. OʼLeary, Theo G.M. van Erp, Arthur W. Toga, Adrian Preda, Kelvin O. Lim, (unknown)	2008	260
17	Novel treatment options for triple-negative breast cancers Molecular Cancer Therapeutics ·Kedar Hastak, Elizabeth Alli, James M. Ford	2007	1
18	Molecular Inversion Probe Analysis of Gene Copy Alterations Reveals Distinct Categories of Colorectal Carcinoma Cancer Research ·Hanlee P. Ji, Jochen Kumm, Michael Zhang, B. N. Aishwarya, Keyan Salari, Malek Faham, James M. Ford, Ronald W. Davis	2006	21
19	p53 and DNA damage-inducible expression of the xeroderma pigmentosum group C gene Proceedings of the National Academy of Sciences ·Shanthi Adimoolam, James M. Ford	2002	259
20	Cancer Chemotherapy: Principles and Practice The Yale Journal of Biology and Medicine ·James M. Ford	1991	3

About James M. Ford

James M. Ford is a scholar working on Cancer Research, Oncology, Genetics, Pathology and Forensic Medicine and Molecular Biology, having authored 332 papers that have together received 17.7k indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (75 papers), Cancer Genomics and Diagnostics (68 papers), DNA Repair Mechanisms (58 papers), Genetic factors in colorectal cancer (42 papers), Cancer-related Molecular Pathways (30 papers), Pancreatic and Hepatic Oncology Research (27 papers), PARP inhibition in cancer therapy (23 papers) and Gastric Cancer Management and Outcomes (19 papers). The work is most often cited by research in Oncology (7.7k citations), Cancer Research (3.5k citations), Pathology and Forensic Medicine (2.7k citations), Genetics (3.2k citations) and Molecular Biology (7.0k citations). James M. Ford has collaborated with scholars based in United States, United Kingdom and Hong Kong. Frequent co-authors include W N Hait, Philip C. Hanawalt, Shanthi Adimoolam, George A. Fisher, Allison W. Kurian, P.C. Hanawalt, Albert C. Koong, Gilbert Chu, Byung Joon Hwang and Anne‐Renee Hartman. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics, Cancer Research, Schizophrenia Bulletin and DNA repair.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact